Margotat A, Sarkissian G, Malezet-Desmoulins C, Peyrol N, Vlaeminck Guillem V, Wémeau J L, Torresani J
INSERM U476 Faculté de Médecine, 27, boulevard Jean-Moulin, 13385 Marseille Cedex 5.
Ann Endocrinol (Paris). 2001 Jun;62(3):220-5.
Resistance to thyroid hormone (RTH) is a rare genetic disorder, usually associated with different mutations in the c-erbAB gene that encodes the beta type receptor of thyroid hormone (TRB). It is characterized by elevated serum thyroid hormone and inappropriate TSH secretion. The numerous mutations so far detected are clustered in three hot spot areas in the ligand binding domain of TRB. In the context of a national survey we have detected 16 different mutations in the c-erbAB gene, in 22 families presenting with RTH. Eight of these mutations had not been described previously. Two are located in an area not known to harbor naturally occurring mutations. This observation could lead to define a fourth cluster of mutations in the c-erbAB gene.
甲状腺激素抵抗(RTH)是一种罕见的遗传性疾病,通常与编码甲状腺激素β型受体(TRB)的c-erbAB基因中的不同突变有关。其特征是血清甲状腺激素升高和促甲状腺激素(TSH)分泌异常。迄今为止检测到的众多突变集中在TRB配体结合域的三个热点区域。在一项全国性调查中,我们在22个患有RTH的家庭中检测到c-erbAB基因中的16种不同突变。其中8种突变以前未曾描述过。两种位于一个未知有自然发生突变的区域。这一观察结果可能导致确定c-erbAB基因中的第四组突变。